Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: A dual role for IGFBP-5
- 1 October 1998
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 177 (1) , 47-57
- https://doi.org/10.1002/(sici)1097-4652(199810)177:1<47::aid-jcp5>3.0.co;2-e
Abstract
We have previously shown that the insulin-like growth factors (IGFs) stimulate both proliferation and differentiation of skeletal muscle cells in culture, and that these actions in L6A1 muscle cells may be modulated by three secreted IGF binding proteins (IGFBPs), IGFBP-4, -5, and -6. Since we found that the temporal expression pattern of IGFBP-4 and IGFBP-5 differed dramatically during the transition from proliferating myoblasts to differentiated myotubes, we undertook the current study to examine the effects of purified IGFBP-4 and IGFBP-5 on IGF- stimulated actions in L6A1 muscle cells. As has been shown for other cell types, we found that IGFBP-4 had only inhibitory actions, inhibiting IGF-I and IGF-II- stimulated proliferation and differentiation. In contrast, IGFBP-5 exhibited both inhibitory and stimulatory actions. When added in the presence of 30 ng/ml IGF-I, IGFBP-5 (250 ng/ml) inhibited all markers of the early proliferative response: the tyrosine phosphorylation of the cytoplasmic signaling molecules IRS-1 and Shc, the activation of the MAP kinases, ERK1 and 2, the elevation of c-fos mRNA, the early inhibition of the elevation in myogenin mRNA, and the increase in cell number. In contrast, IGFBP-5 stimulated all aspects of the myogenic response to IGF-I: the later rise in myogenin mRNA, the elevation of creatine kinase activity, and the fusion of myoblasts into myotubes. This dual response to IGFBP-5 was greatest when it was added at a molar ratio of IGFBP-5 to IGF-I of 2:1. In contrast, when IGFBP-5 was added in the presence of IGF-II, it inhibited both proliferation and differentiation. Neither IGFBP had any effect when added in the presence of R3 IGF-I, an analog with substantially reduced affinity for IGFBPs. Our results suggest that the role of IGFBP-4 is mainly to sequester excess IGFs, and thus inhibit all actions. IGFBP-5, however, is capable of eliciting a dual response, possibly due to its unique ability to associate with the cell membrane. J. Cell. Physiol. 177:47–57, 1998.Keywords
This publication has 40 references indexed in Scilit:
- The Mitogenic and Myogenic Actions of Insulin-like Growth Factors Utilize Distinct Signaling PathwaysJournal of Biological Chemistry, 1997
- Proliferation precedes differentiation in IGF-I-stimulated myogenesis.The Journal of cell biology, 1996
- Phosphatidylinositol 3-Kinase Inhibitors Block Differentiation of Skeletal Muscle CellsJournal of Biological Chemistry, 1996
- Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism.The Journal of cell biology, 1996
- Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.Journal of Clinical Investigation, 1995
- Involvement of Src‐homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin‐like‐growth‐factor‐I‐receptorEuropean Journal of Biochemistry, 1994
- Carboxy-Truncated Insulin-like Growth Factor-Binding Protein-5 Stimulates Mitogenesis in Osteoblast-like CellsBiochemical and Biophysical Research Communications, 1993
- Induction and peak gene expression of insulin-like growth factor II follow that of myogenin during differentiation of BC3H-1 muscle cellsBiochemical and Biophysical Research Communications, 1992
- Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: A potential candidate for fixing IGF-II in human boneBiochemical and Biophysical Research Communications, 1991
- Effects of the somatomedins and insulin on myoblast differentiation in vitroDevelopmental Biology, 1981